ArticleTherapeutic innovation & regulatory science2025

Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody Drugs.

Hiromu Yoshiura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.